Pharma Journalist -

DNAnexus, Inc. and Twist Bioscience Corporation announced a collaboration aimed at accelerating research and reducing the time to design, validate, and commercialize new, high-quality,…
Read More...

AVROBIO, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation for AVR-RD-05, its gene therapy for the treatment of mucopolysaccharidosis…
Read More...

Innoviva, Inc. announced that the company has entered into an agreement to sell its 15% economic stake in Theravance Respiratory Company LLC (“TRC”), which receives royalties stemming…
Read More...

Solvias announced that it has acquired Utrecht, Netherlands-based Cergentis. The acquisition bolsters Solvias' platform of biologics and cell and gene therapy (CGT) testing solutions.…
Read More...

Discovery Life Sciences (Discovery), the biospecimen and biomarker specialists, announced its acquisition of AllCells, a leading provider of clinical-grade (GMP-compliant) and Research…
Read More...

On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T…
Read More...

Bicycle Therapeutics plc announced that Genentech, a member of the Roche Group, has exercised its second option to initiate a new program, expanding the exclusive strategic…
Read More...

Inspirna, Inc., a clinical stage biopharmaceutical company developing first-in-class small molecule therapeutics, announced that it has raised $50 million in a Series D financing round,…
Read More...

Anthos Therapeutics, a clinical-stage biotechnology company developing innovative therapies for cardiovascular and metabolic diseases, announced that the U.S. Food and Drug…
Read More...

Thermo Fisher Scientific announced the launch of the Applied Biosystems TaqPath Respiratory Viral Select Panel; a CE-IVD-marked molecular assay panel for detection of five common…
Read More...